The World Health Organization (WHO) defines antimicrobial resistance (AMR) as resistance of a microorganism to an antimicrobial medicine to which it was originally sensitive. Resistant organisms (including bacteria, fungi, viruses and some parasites) are able to withstand antimicrobial medicines (such as antibiotics, antifungals, antivirals, and antimalarials) so that standard treatments become ineffective and infections persist, increasing the risk of spread to others. The development of AMR is a natural phenomenon but certain human actions accelerate the emergence and spread of AMR.
The scale of the threat of antimicrobial resistance (AMR) and the case for action was set out in the Annual Report of the Chief Medical Officer 2011, published in March 2013. The Government’s UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 sets out actions to address the problem of AMR.
The Science and Technology Committee has agreed to hold an inquiry into antimicrobial resistance. Chair of the Committee Andrew Miller MP stated:
“Antimicrobial resistance is one of the most significant threats to public health today. I am pleased that Dame Sally Davies, Chief Medical Officer, is taking this seriously. However, we want to find out whether the Government’s current and proposed actions will contribute enough to tackling this serious global threat.”
26 Feb 2014 - Antimicrobial resistance (AMR) - oral evidence
Published 10 Mar 2014
Evidence given by Professor Jeremy Farrar, Director, Wellcome Trust, Professor Sir John Savill, Chief Executive Officer, Medical Research Council (representing the Research Councils UK), Kush Naker, Policy and Advocacy Co-ordinator, Universities Allied for Essential Medicines UK, and Professor Sir Anthony Coates, Professor of Medical Microbiology, Antibiotic Discovery UK; Dr Louise Leong, Head of Research and Development, Association of the British Pharmaceutical Industry, James Anderson, Director, European Partnerships, GlaxoSmithKline, Dr David Williams, Chief Executive Officer, Discuva, and Michael McIntyre, Chair, European Herbal and Traditional Medicine Practitioners Association.
29 Jan 2014 - Antimicrobial resistance (AMR) - oral evidence
Published 05 Feb 2014
Evidence given by Phil Sketchley, Chief Executive, National Office of Animal Health, John FitzGerald, Secretary General, Responsible Use of Medicines in Agriculture Alliance, Catherine McLaughlin, Animal Health and Welfare Adviser, National Farmers’ Union, and Cóilín Nunan, Principal Scientific Adviser, Alliance to Save our Antibiotics
08 Jan 2014 - Antimicrobial resistance (AMR) - oral evidence
Published 13 Jan 2014
Evidence given by Professor Anthony Kessel, Director, Public Health Strategy, Public Health England, Dr Michael Moore, National Clinical Champion Antibiotic Stewardship, Royal College of General Practitioners, Professor Alison Holmes, Director of Infection Prevention and Control, National Centre for Infection Prevention and Management, Imperial College London, and Dr Susan Hopkins, Chair, Healthcare Associated Infections Working Group, Royal College of Physicians; John Hardcastle, Chief Executive Officer, Novolytics, Dr David McIntosh, Global Scientific Affairs Senior Expert, Novartis, Professor George Lewith, Professor of Health Research, University of Southampton Medical School, and Doris-Ann Williams, Chief Executive, British In Vitro Diagnostics Association
18 Dec 2013 - Antimicrobial resistance (AMR) - oral evidence
Published 02 Jan 2014
Evidence given by Dr Pat Goodwin, Society of Biology, Professor Laura Piddock, British Society for Antimicrobial Chemotherapy, Professor John Threlfall, Society for Applied Microbiology, and Professor Sharon Peacock, Cambridge Infectious Diseases Initiative, University of Cambridge.